Thursday, October 26, 2017 1:02:10 PM
https://www.prnewswire.com/news-releases/medivir-ab--interim-report-january--september-2017-300543749.html
I can't speak for others, but I'm getting rather frustrated as to Medivir's lack of communication regarding the Tetralogic asset purchase agreement. Medivir appears to have taken the position that updates pertaining to the TLOG asset purchase agreement will only be through MVIR-B stock SEC filings. Considering the amount of money associated with the APA, I intend to seek subject matter expertise regarding the matter. I hold to large of a position for MVIR management to potentially discount their fiduciary responsibilities as related to our potential milestone and royalty payments.
Not implying any wrong doing but just as MVIR protects their financial interests, in my opinion it's time for TLOG stakeholders to protect theirs.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM